COMMUNIQUÉS West-GlobeNewswire
-
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
24/06/2026 -
Noom Launches Free Version of Its Powerful GLP-1 Companion — Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts
24/06/2026 -
Applied Biologics Announces Completion of Translational Research Supporting the Biologic Performance of XWRAP®
24/06/2026 -
SoldierStrong Donates Real® i-Series System to VA Boston Healthcare System to Advance Veteran Wellness and Mental Health Care
24/06/2026 -
Rendever Brings Social Prescribing to Senior Living with CommunityOS
24/06/2026 -
Femasys Regains Compliance with Nasdaq Listing Requirements
24/06/2026 -
Labviva Launches “The Agentic Crew”: A Purpose-Built AI Architecture to Transform Procurement in Regulated Industries
24/06/2026 -
Caregivers in Crisis: New Survey from Aeroflow Urology Reveals 77% of Caregivers are Drowning in Costs as Out-of-Pocket Expenses Reach a Breaking Point
24/06/2026 -
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
24/06/2026 -
RAMSAY SANTE launches senior debt refinancing
24/06/2026 -
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
24/06/2026 -
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
24/06/2026 -
MapLight Therapeutics Announces Changes to Board of Directors
24/06/2026 -
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
24/06/2026 -
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
24/06/2026 -
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24/06/2026 -
SRX Global Announces Share Consolidation
24/06/2026 -
Mammogen Appoints Physician Executive and Breast Imaging Leader, Dr. Elise Berman, as Chief Medical Officer
24/06/2026 -
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24/06/2026
Pages